#119513
Re: Farmas USA
ARNA
Arena Pharmaceuticals' Presence at the European Crohn's and Colitis Organisation (ECCO) Congress Further Highlights Commitment to the GI Community
- New biomarker data from the open-label extension (OLE) of the Phase 2 OASIS trial for etrasimod in patients with moderately to severely active ulcerative colitis (UC)
- Arena sponsored dinner symposium: HYPE, HOPE or REALITY? Integrating histology into a treat-to-target strategy in UC, with Chair: Professor William J. Sandborn, MD
- Arena of Care™ Award in Inflammatory Bowel Disease (IBD) - A competitive grant designed to fund novel patient-centric research for the IBD community
http://invest.arenapharm.com/news-releases/news-release-details/arena-pharmaceuticals-presence-european-crohns-and-colitis
http://invest.arenapharm.com/news-releases/news-release-details/arena-pharmaceuticals-presence-european-crohns-and-colitis
«Después de nada, o después de todo/ supe que todo no era más que nada.»